{
  "report_rows": [
    {
      "kpi": "GAAP diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.88 vs. cons $2.83",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "BEAT",
      "answer": "pred ~2.5% vs. cons 1.9%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating margin",
      "prediction": "IN-LINE",
      "answer": "pred ~26.8% vs. cons 26.7%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 GAAP EPS guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~$11.30 vs. cons $11.35 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 organic-growth guidance midpoint",
      "prediction": "LOWER",
      "answer": "guide ~2.0% vs. cons 2.2% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 operating-margin guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~27.0% vs. cons 27.0% (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -0.5,
  "day5_path": "FADE",
  "day5_rationale": "A ~$2.88 versus $2.83 quarterly EPS beat and ~2.5% versus 1.9% organic-growth beat should support an initial ~1.5% residual move, but retaining the ~$11.30 FY2026 EPS midpoint versus ~$11.35 consensus leaves implied second-half EPS at roughly ~$5.76 versus ~$5.87, creating modest out-period revision risk and a fade to about -0.5% by day five.",
  "day5_confidence": "MEDIUM"
}